Evidence map›Paper›PMID 11106609›Full record

ArticleBiophysical journal2000

Block of wild-type and inactivation-deficient cardiac sodium channels IFM/QQQ stably expressed in mammalian cells.

A O Grant, R Chandra, C Keller, M Carboni, C F Starmer

Abstract read
In one paragraph

Article in Biophysical journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Anomalous enhancement of resurgent NaScientific reports · 2019
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Local anesthetic inhibition of a bacterial sodium channel.The Journal of general physiology · 2012
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Pharmacogenetics and anti-arrhythmic drug therapy: a theoretical investigation.American journal of physiology. Heart and circulatory physiology · 2007
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A O GrantDepartments of Medicine and Pediatrics, Duke University, Durham, NC 27706, USA. aog@carlin.mc.duke.edu
R Chandra
C Keller
M Carboni
C F Starmer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of inactivation as a central mechanism in blockade of the cardiac Na(+) channel by antiarrhythmic drugs remains uncertain. We have used whole-cell and single channel recordings to examine the block of wild-type and inactivation-deficient mutant cardiac Na(+) channels, IFM/QQQ, stably expressed in HEK-293 cells. We studied the open-channel blockers disopyramide and flecainide, and the lidocaine derivative RAD-243. All three drugs blocked the wild-type Na(+) channel in a use-dependent manner. There was no use-dependent block of IFM/QQQ mutant channels with trains of 20 40-ms pulses at 150-ms interpulse intervals during disopyramide exposure. Flecainide and RAD-243 retained their use-dependent blocking action and accelerated macroscopic current relaxation. All three drugs reduced the mean open time of single channels and increased the probability of their failure to open. From the abbreviation of the mean open times, we estimated association rates of approximately 10(6)/M/s for the three drugs. Reducing the burst duration contributed to the acceleration of macroscopic current relaxation during exposure to flecainide and RAD-243. The qualitative differences in use-dependent block appear to be the result of differences in drug dissociation rate. The inactivation gate may play a trapping role during exposure to some sodium channel blocking drugs.

Indexed as

Amino Acid SubstitutionAnti-Arrhythmia AgentsCell LineCloning, MolecularDisopyramideFlecainideHeartHumansLidocaineMembrane PotentialsModels, BiologicalMyocardiumRecombinant ProteinsSodium Channel BlockersSodium ChannelsTransfectionAnti-Arrhythmia AgentsDisopyramideFlecainideLidocaineRAD 243Recombinant ProteinsSodium Channel BlockersSodium Channels

Identifiers

PMID11106609
PMCPMC1301180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.